Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PBRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EGFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAD2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TNFSF12-TNFSF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBQLN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPA1P33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEFF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YWHAZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMIGO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC88A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD14B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUMO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBLAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on